Trial Profile
Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastric cancer
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 07 Aug 2014 New trial record